HCW Biologics Inc.HCW Biologics Inc.HCW Biologics Inc.

HCW Biologics Inc.

No trades
See on Supercharts
Market capitalization
‪62.79 M‬USD
−0.70USD
‪−24.99 M‬USD
‪2.84 M‬USD
‪16.82 M‬
Beta (1Y)
−0.32

About HCW Biologics Inc.

CEO
Hing C. Wong
Headquarters
Miramar
Employees (FY)
45
Founded
2018
ISIN
US40423R1059
FIGI
BBG011769443
HCW Biologics Inc. is a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammation, and age-related diseases. The firm considers age-related low-grade chronic inflammation as a contributing factor to several chronic diseases and conditions, such as cancer, cardiovascular disease, diabetes, neurodegenerative diseases, and autoimmune diseases. The company was founded by Hing C. Wong on April 2, 2018 and is headquartered in Miramar, FL.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of HCWB is 1.66 USD — it has increased by 4.40% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange HCW Biologics Inc. stocks are traded under the ticker HCWB.
HCW Biologics Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
HCWB stock is 11.33% volatile and has beta coefficient of −0.32. Check out the list of the most volatile stocks — is HCW Biologics Inc. there?
One year price forecast for HCW Biologics Inc. has a max estimate of 4.00 USD and a min estimate of 4.00 USD.
HCWB earnings for the last quarter are −0.14 USD per share, whereas the estimation was −0.13 USD resulting in a −7.69% surprise. The estimated earnings for the next quarter are −0.15 USD per share. See more details about HCW Biologics Inc. earnings.
HCW Biologics Inc. revenue for the last quarter amounts to ‪853.10 K‬ USD despite the estimated figure of ‪600.00 K‬ USD. In the next quarter revenue is expected to reach ‪900.00 K‬ USD.
Yes, you can track HCW Biologics Inc. financials in yearly and quarterly reports right on TradingView.
HCWB stock has risen by 7.10% compared to the previous week, the month change is a 7.26% fall, over the last year HCW Biologics Inc. has showed a 13.70% increase.
HCWB net income for the last quarter is ‪−10.68 M‬ USD, while the quarter before that showed ‪−4.94 M‬ USD of net income which accounts for −116.26% change. Track more HCW Biologics Inc. financial stats to get the full picture.
Today HCW Biologics Inc. has the market capitalization of ‪62.79 M‬, it has decreased by 6.63% over the last week.
No, HCWB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, HCWB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HCW Biologics Inc. stock right from TradingView charts — choose your broker and connect to your account.
HCWB reached its all-time high on Jul 20, 2021 with the price of 7.78 USD, and its all-time low was 0.91 USD and was reached on Nov 15, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 45.00 employees. See our rating of the largest employees — is HCW Biologics Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HCW Biologics Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HCW Biologics Inc. stock shows the sell signal. See more of HCW Biologics Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on HCW Biologics Inc. future price: according to them, HCWB price has a max estimate of 4.00 USD and a min estimate of 4.00 USD. Read a more detailed HCW Biologics Inc. forecast: see what analysts think of HCW Biologics Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HCW Biologics Inc. EBITDA is ‪−24.58 M‬ USD, and current EBITDA margin is −865.02%. See more stats in HCW Biologics Inc. financial statements.